DalsnaFinance Account

Corteva $CTVA

Materials · Fertilizers & Agricultural Chemicals

Russell 1000 Indiana

Create a scorecard

$12.90

+0.25 (+1.98%)

As of Oct 20, 2026, 5:47 PM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 6, 2026, the first target we tracked for CTVA.

Corteva (CTVA) is trading up at $12.90 (+1.98%), as of the latest quote. It is a Russell 1000 constituent in the Materials sector.

Analyst price targets on CTVA

Current price targets from 5 firms average $18, median $17, ranging from $17 to $20 — the average is 40% above the current $12.9. Each is tracked to its date and scored the same way a member's call is.

RBC Capital Markets $14.4 → $17 by Oct 2027 Outperform Oct 8, 2026 via Investing.com · RBC Capital Markets's track record
Oppenheimer $14.4 → $17 by Oct 2027 Outperform Oct 8, 2026 via Investing.com · Oppenheimer's track record
Goldman Sachs $14.4 → $20 by Oct 2027 Buy Oct 8, 2026 via Investing.com · Goldman Sachs's track record
KeyBanc Capital Markets $13.9 → $17 by Oct 2027 Overweight Oct 7, 2026 via Investing.com · KeyBanc Capital Markets's track record
JPMorgan $12.4 → $19 by Oct 2027 Overweight Oct 6, 2026 via Investing.com · JPMorgan's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Corteva revenue & net income history (FY2018–FY2025)

RevenueNet incomeNet margin (right axis, %)

Corteva annual financial statements
	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$14.3B	$13.8B	$14.2B	$15.7B	$17.5B	$17.2B	$16.9B	$17.4B
Growth (year over year)	—	−3.1%	+2.7%	+10.1%	+11.5%	−1.3%	−1.8%	+2.9%
Gross profit	$4.34B	$5.27B	$5.71B	$6.43B	$7.02B	$7.31B	$7.38B	$8.23B
Gross margin	30.4%	38.1%	40.2%	41.1%	40.2%	42.4%	43.6%	47.3%
Net income	−$5.07B	−$959.0M	$681.0M	$1.76B	$1.15B	$735.0M	$907.0M	$1.09B
Net margin	−35.5%	−6.9%	4.8%	11.2%	6.6%	4.3%	5.4%	6.3%
EPS (diluted)	−$6.76	−$1.28	$0.91	$2.37	$1.58	$1.03	$1.30	$1.60
Balance sheet
Cash and equivalents	$2.27B	$1.76B	$3.53B	$4.46B	$3.19B	$2.64B	$3.11B	$4.52B
Total assets	$108.7B	$42.4B	$42.6B	$42.3B	$42.6B	$43.0B	$40.8B	$42.8B
Total liabilities	$33.5B	$17.8B	$17.6B	$16.7B	$17.1B	$17.7B	$16.8B	$18.5B
Long-term debt	$5.78B	$115.0M	$1.10B	$1.10B	$1.28B	$2.29B	$1.95B	$1.69B
Shareholders' equity	$74.7B	$24.3B	$24.8B	$25.4B	$25.3B	$25.0B	$23.8B	$24.1B
Cash flow
Operating cash flow	$483.0M	$1.07B	$2.06B	$2.73B	$872.0M	$1.77B	$2.15B	$3.41B
Capital expenditure	$1.50B	$1.16B	$475.0M	$573.0M	$605.0M	$595.0M	$597.0M	$591.0M
Free cash flow	−$1.02B	−$93.0M	$1.59B	$2.15B	$267.0M	$1.17B	$1.55B	$2.81B
Dividends paid	$0	−$194.0M	−$388.0M	$397.0M	$418.0M	$439.0M	$458.0M	$475.0M
Share buybacks	$0	$25.0M	$275.0M	$950.0M	$1.00B	$756.0M	$1.01B	$1.07B

RevenueNet incomeNet margin (right axis, %)

Corteva quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$2.33B	$3.98B	$4.42B	$6.46B	$2.62B	$3.91B	$4.91B	$6.38B
Growth (year over year)	−10.2%	+7.3%	−1.7%	+5.6%	+12.6%	−1.7%	+11.0%	−1.2%
Gross profit	$761.0M	$1.48B	$2.08B	$3.52B	$974.0M	$1.66B	$2.53B	$3.66B
Gross margin	32.7%	37.3%	47.0%	54.6%	37.2%	42.4%	51.6%	57.4%
Net income	−$524.0M	−$41.0M	$652.0M	$1.31B	−$320.0M	−$552.0M	$720.0M	$1.16B
Net margin	−22.5%	−1.0%	14.8%	20.4%	−12.2%	−14.1%	14.7%	18.2%
EPS (diluted)	−$0.76	−$0.05	$0.95	$1.92	−$0.47	−$0.80	$1.07	$1.73
Balance sheet
Cash and equivalents	$2.42B	$3.11B	$2.01B	$2.06B	$2.51B	$4.52B	$1.96B	$2.37B
Total assets	$41.9B	$40.8B	$42.1B	$41.8B	$42.2B	$42.8B	$42.7B	$41.6B
Total liabilities	$16.9B	$16.8B	$17.6B	$15.6B	$16.7B	$18.5B	$18.1B	$16.2B
Long-term debt	$1.98B	$1.95B	$1.79B	$1.69B	$1.69B	$1.69B	$1.68B	$1.68B
Shareholders' equity	$24.7B	$23.8B	$24.3B	$25.9B	$25.2B	$24.1B	$24.4B	$25.2B
Cash flow
Operating cash flow	$130.0M	$4.17B	−$2.11B	$947.0M	$193.0M	$4.38B	−$2.89B	−$466.0M
Capital expenditure	$154.0M	$181.0M	$94.0M	$118.0M	$157.0M	$222.0M	$81.0M	$122.0M
Free cash flow	−$24.0M	$3.99B	−$2.20B	$829.0M	$36.0M	$4.15B	−$2.97B	−$588.0M
Dividends paid	$117.0M	$118.0M	$116.0M	$116.0M	$122.0M	$121.0M	$121.0M	$120.0M
Share buybacks	$253.0M	$252.0M	$270.0M	$250.0M	$250.0M	$301.0M	$250.0M	$250.0M

From Corteva's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Corteva

Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International.

Source: Wikipedia — Corteva